Skip to content
Biodatica
Start free

Investigator

Peter D. Adams

UNIVERSITY OF PENNSYLVANIA · funded by NIA, NIAMS, NCI

Companies
12

Resolved onto their grants.

Grants
15

Federal awards on file.

Non-dilutive funding
$11M

Summed across those awards.

First award
May 1, 1997

Latest Feb 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. P01

    Project 1: Epigenetic control of cell identity and inflammation in aging

    $401k

    Feb 1, 2026NIAUNIVERSITY OF PENNSYLVANIANIH RePORTER · 11096619 (opens the source filing in a new tab)

  2. U54

    Admin Core

    $354k

    Aug 1, 2022NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11134738 (opens the source filing in a new tab)

  3. U54

    Bioanalysis Core

    $1.8M

    Aug 1, 2022NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11134741 (opens the source filing in a new tab)

  4. U54

    Spatial mapping senescent cells across the mouse lifespan by multiplex transcriptomics and epigenomics

    $2.7M

    Aug 1, 2022NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11134736 (opens the source filing in a new tab)

  5. U54

    Admin Core

    $67k

    Aug 1, 2022NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11387279 (opens the source filing in a new tab)

  6. U54

    Spatial Mapping Senescent Cells Across the Mouse Lifespan by Multiplex Transcriptomics and Epigenomics

    $199k

    Aug 1, 2022NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11363960 (opens the source filing in a new tab)

  7. P01

    Core A: Administrative

    $361k

    Sep 15, 2021NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11160728 (opens the source filing in a new tab)

  8. P01

    Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging

    $361k

    Sep 15, 2021NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11160733 (opens the source filing in a new tab)

  9. P01

    Aging as a Risk Factor and Target for Prevention of Liver Cancer

    $2.5M

    Sep 15, 2021NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11160726 (opens the source filing in a new tab)

  10. R01

    Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells

    $620k

    Aug 4, 2021NIAMSSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11098526 (opens the source filing in a new tab)

  11. R01

    Cytoplasmic chromatin fragments in cell senescence - novel mechanisms and interventions

    $420k

    May 1, 2021NIASANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11023097 (opens the source filing in a new tab)

  12. P30

    Genomics

    $255k

    May 1, 1997NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11319377 (opens the source filing in a new tab)

  13. P30

    Cancer Genome & Epigenetics

    $255k

    May 1, 1997NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11319390 (opens the source filing in a new tab)

  14. P30

    Genomics

    $257k

    May 1, 1997NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11332998 (opens the source filing in a new tab)

  15. P30

    Cancer Genome & Epigenetics

    $119k

    May 1, 1997NCISANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTENIH RePORTER · 11333007 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources